BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26334094)

  • 1. Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma.
    Zhuang L; Xu L; Wang P; Jiang Y; Yong P; Zhang C; Zhang H; Meng Z; Yang P
    Oncotarget; 2015 Sep; 6(29):28183-93. PubMed ID: 26334094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Na(+)/K(+)-ATPase alpha1 subunit of hepatoma HepG2 cell line to induce apoptosis and cell cycle arresting.
    Xu ZW; Wang FM; Gao MJ; Chen XY; Hu WL; Xu RC
    Biol Pharm Bull; 2010; 33(5):743-51. PubMed ID: 20460749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufalin Inhibits Tumorigenesis and SREBP-1-Mediated Lipogenesis in Hepatocellular Carcinoma via Modulating the ATP1A1/CA2 Axis.
    Huang CJ; Zhang CY; Zhao YK; Wang D; Zhuang L; Qian L; Xie L; Zhu Y; Meng ZQ
    Am J Chin Med; 2023; 51(2):461-485. PubMed ID: 36655687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Na(+)/K(+)-ATPase alpha1 siRNA and ouabain upon cell cycle in human hepatoma HepG2 cell and its mechanism].
    Xu ZW; Wang FM; Xu RC; Hu WL; Chen XY
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):813-7. PubMed ID: 20450619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide-Treated Human Hepatocellular Carcinoma Cell Line HepG2.
    Luo Y; Wen X; Wang L; Gao J; Wang Z; Zhang C; Zhang P; Lu C; Duan L; Tian Y
    Oxid Med Cell Longev; 2016; 2016():7530853. PubMed ID: 27597883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q; Cai W; Zhang M; Liu Q; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and inhibitory role of TIMP-3 in hepatocellular carcinoma.
    Shen B; Jiang Y; Chen YR; Zheng HC; Zeng W; Li YY; Yin A; Nie Y
    Oncol Rep; 2016 Jul; 36(1):494-502. PubMed ID: 27222429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
    Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
    Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
    Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
    J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Long Non-Coding RNA, the Antisense RNA of Na/K-ATPase α1 in Human Kidney Cells.
    Fan X; Ashraf UM; Drummond CA; Shi H; Zhang X; Kumarasamy S; Tian J
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells.
    Xu D; He XX; Chang Y; Sun SZ; Xu CR; Lin JS
    Hepatogastroenterology; 2012; 59(120):2367-73. PubMed ID: 22773266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.
    Liu RR; Lv YS; Tang YX; Wang YF; Chen XL; Zheng XX; Xie SZ; Cai Y; Yu J; Zhang XN
    Oncotarget; 2016 Apr; 7(17):24348-60. PubMed ID: 27028999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Proteomics Reveals That the Inhibition of Na(+)/K(+)-ATPase Activity Affects S-Phase Progression Leading to a Chromosome Segregation Disorder by Attenuating the Aurora A Function in Hepatocellular Carcinoma Cells.
    Xu Z; Wang F; Fan F; Gu Y; Shan N; Meng X; Cheng S; Liu Y; Wang C; Song Y; Xu R
    J Proteome Res; 2015 Nov; 14(11):4594-602. PubMed ID: 26491887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
    Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
    Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
    Liu S; Zhang W; Liu K; Ji B; Wang G
    Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.